| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GKOS | Common Stock | Options Exercise | $437K | +60K | +107.46% | $7.28* | 116K | Jan 8, 2024 | Direct | F1 |
| transaction | GKOS | Common Stock | Sale | -$187K | -2.31K | -2% | $80.65 | 114K | Jan 8, 2024 | Direct | F1, F2, F3 |
| transaction | GKOS | Common Stock | Sale | -$1.03M | -12.6K | -11.11% | $81.50 | 101K | Jan 8, 2024 | Direct | F1, F2, F4 |
| transaction | GKOS | Common Stock | Sale | -$1.92M | -23.3K | -23.09% | $82.38 | 77.6K | Jan 8, 2024 | Direct | F1, F2, F5 |
| transaction | GKOS | Common Stock | Sale | -$1.49M | -17.9K | -23.03% | $83.38 | 59.7K | Jan 8, 2024 | Direct | F1, F2, F6 |
| transaction | GKOS | Common Stock | Sale | -$328K | -3.9K | -6.53% | $84.21 | 55.8K | Jan 8, 2024 | Direct | F1, F2, F7 |
| transaction | GKOS | Common Stock | Options Exercise | $837 | +115 | +0.21% | $7.28* | 56K | Jan 9, 2024 | Direct | F1 |
| transaction | GKOS | Common Stock | Sale | -$425 | -5 | -0.01% | $85.00 | 55.9K | Jan 9, 2024 | Direct | F1, F2 |
| transaction | GKOS | Common Stock | Sale | -$6.33K | -73 | -0.13% | $86.74 | 55.9K | Jan 9, 2024 | Direct | F1, F2, F8 |
| transaction | GKOS | Common Stock | Sale | -$3.23K | -37 | -0.07% | $87.33 | 55.8K | Jan 9, 2024 | Direct | F1, F2, F9 |
| holding | GKOS | Common Stock | 894K | Jan 8, 2024 | Through the Burns Family Trust | ||||||
| holding | GKOS | Common Stock | 238K | Jan 8, 2024 | Through the Burns Annuity Trust | ||||||
| holding | GKOS | Common Stock | 120K | Jan 8, 2024 | Through the Burns Charitable Remainder Trust | ||||||
| holding | GKOS | Common Stock | 100K | Jan 8, 2024 | Through the Thomas W. Burns Irrevocable Trust | ||||||
| holding | GKOS | Common Stock | 100K | Jan 8, 2024 | Through the Janet M. Burns Irrevocable Trust |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | GKOS | Stock Option (Right to Buy) | Options Exercise | $0 | -60K | -99.81% | $0.00 | 115 | Jan 8, 2024 | Common Stock | 60K | $7.28 | Direct | F10, F11 |
| transaction | GKOS | Stock Option (Right to Buy) | Options Exercise | $0 | -115 | -100% | $0.00* | 0 | Jan 9, 2024 | Common Stock | 115 | $7.28 | Direct | F10, F11 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Includes 47,177 restricted stock units that have not yet vested or been delivered to the Reporting Person. |
| F2 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 24, 2023. |
| F3 | This transaction was executed in multiple trades at prices ranging from $80.00 to $80.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F4 | This transaction was executed in multiple trades at prices ranging from $81.00 to $81.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F5 | This transaction was executed in multiple trades at prices ranging from $82.00 to $82.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F6 | This transaction was executed in multiple trades at prices ranging from $83.00 to $83.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F7 | This transaction was executed in multiple trades at prices ranging from $84.05 to $84.39. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F8 | This transaction was executed in multiple trades at prices ranging from $86.25 to $87.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F9 | This transaction was executed in multiple trades at prices ranging from $87.26 to $88.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F10 | The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 24, 2023. |
| F11 | This option was granted on July 10, 2014 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant date. |